# Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery

> **NCT04636567** · PHASE2 · WITHDRAWN · sponsor: **Li-Cor, Inc.**

## Conditions studied

- Intraoperative Ureter Injury

## Interventions

- **DRUG:** Nerindocianine for injection

## Key facts

- **NCT ID:** NCT04636567
- **Lead sponsor:** Li-Cor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-03
- **Primary completion:** 2021-07
- **Final completion:** 2021-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Clinical program has been suspended for business reasons.
- **Last updated:** 2021-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636567, "Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04636567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*